OakChart

Exagen Inc

XGNHealthcare·Diagnostics & Research·USA·Micro·NASD·Nov 11 • 3:59 PM ET

5.03-0.23 (-4.28%)
2026-11-12 04:35 CET
Market cap
121.97 USD m
Revenue, TTM
72.30 USD m
Net income, TTM
-18.17 USD m
Free cash flow, TTM
-13.03 USD m
EPS diluted, TTM
-0.75
P/E
-
Compare

Price

XGN against its 20, 50 and 200-day averages
2050200beatmiss
4.006.008.003.1M6.2MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26XGNclose 5.0420-day 7.5450-day 7.84200-day 5.125.0452w low

48.3% under the 52-week high of 9.74 on 13 Nov 2025. 52-week low 2.59 on 30 Mar 2026. Last 15 sessions, 92.8% high to low

Volume 3.35× normal · the line is the 50-bar volume average

Profile

XGN
52-week range, 34% of the way up
2.599.73

Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.

Employees216
IPOSep 19, 2019
Beta2.30
ATR, 14d0.84
Rel volume3.35
Short float5.05%
Insider own40.57%
Inst own33.75%

Snapshot

6 groups

Valuation

Index-
Market Cap121.98M
Enterprise Value122.65M
Income-18.17M
Sales72.30M
Book/sh0.54
Cash/sh1.16
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees216
IPOSep 19, 2019

Ratios

P/E-
Forward P/E-
PEG-
P/S1.69
P/B9.29
P/C4.34
P/FCF-
EV/EBITDA-
EV/Sales1.70
Quick Ratio3.15
Current Ratio3.46
Debt/Eq2.09
LT Debt/Eq1.91
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.75
EPS next Y-0.54
EPS next Q-0.18
EPS this Y25.19%
EPS next Y22.48%
EPS next 5Y25.02%
EPS past 3/5Y30.65% 6.84%
Sales past 3/5Y13.47% 9.66%
EPS Y/Y TTM18.80%
Sales Y/Y TTM13.67%
EPS Q/Q17.45%
Sales Q/Q6.80%
EarningsNov 10 BMO
EPS/Sales Surpr.-37.29% 0.42%

Ownership

Insider Own40.57%
Insider Trans-0.37%
Inst Own33.75%
Inst Trans-8.78%
ROA-30.75%
ROE-113.88%
ROIC-45.26%
Gross Margin58.74%
Oper. Margin-19.27%
Profit Margin-25.14%
SMA20-33.19%
SMA50-35.76%
SMA200-1.66%
Trades-

Technical

Shs Outstand25.42M
Shs Float14.40M
Short Float5.05%
Short Ratio2.02
Short Interest0.73M
52W High9.73 -48.28%
52W Low2.59 94.40%
Volatility26.34% 11.72%
ATR (14)0.84
RSI (14)32.58
Beta2.30
Rel Volume3.35
Avg Volume359.60K
Volume1,206,103

Performance

Perf Week-40.83%
Perf Month-40.62%
Perf Quarter-23.48%
Perf Half Y45.10%
Perf YTD-17.19%
Perf Year-45.39%
Perf 3Y247.24%
Perf 5Y-64.09%
Perf 10Y-
Recom1.00
Target Price9.71
Prev Close5.26
Price5.03
Change %-4.28%

Analyst ratings

latest 10 of 14
DateActionAnalystRating changeTargetImplied
Sep 11, 2026ResumedRB. Riley SecuritiesBuy$12+138.3%
Jun 25, 2026InitiatedRRoth CapitalBuy$8+58.9%
Sep 11, 2025InitiatedRB. Riley SecuritiesBuy$15+197.9%
Jul 30, 2025UpgradeKKeyBanc Capital MarketsSector Weight → Overweight$12+138.3%
Jul 23, 2025InitiatedCCraig HallumBuy$12+138.3%
Aug 05, 2022DowngradeKKeyBanc Capital MarketsOverweight → Sector Weight
Oct 15, 2021ResumedCCowenOutperform$26+416.4%
Apr 15, 2021InitiatedCCanaccord GenuityBuy$25+396.5%
Nov 10, 2020InitiatedKKeyBanc Capital MarketsOverweight$32+535.6%
Oct 08, 2020InitiatedBBTIG ResearchBuy$18+257.5%

Peers

Mkt cap
TickerCompanyMkt cap
BDSXBiodesix Inc112.22M
CSTLCastle Biosciences Inc1.05B
MYGNMyriad Genetics Inc548.68M
MDXHMDxHealth SA13.98M
FLGTFulgent Genetics Inc718.03M
VCYTVeracyte Inc2.03B
CDNACaredx Inc4.26B
DGXQuest Diagnostics Inc28.46B
NEONeogenomics Inc2.18B
QTRXQuanterix Corp143.39M

Insider trading

9 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Chernett Jorey10% OwnerNov 09 '26Buy6.358,50053,9752,618,540Nov 10 08:04 PM
Chernett Jorey10% OwnerNov 10 '26Buy5.267,08537,2672,625,625Nov 10 08:04 PM
Chernett Jorey10% OwnerNov 06 '26Sale6.1411,26569,1672,610,040Nov 10 08:04 PM
Chernett Jorey10% OwnerOct 19 '26Buy7.4614,000104,4402,618,540Oct 20 08:00 AM
ABALLI JOHNPresident and CEOOct 16 '26Sale7.8734,294269,791805,540Oct 19 04:52 PM
Black Jeffrey G.Chief Financial OfficerSep 01 '26Sale7.2220,614148,782323,339Sep 02 05:39 PM
ABALLI JOHNPresident and CEOMar 03 '26Sale3.6215,69856,827687,299Mar 04 03:00 PM
ABALLI JOHNPresident and CEOFeb 24 '26Sale3.6111,43041,262702,997Feb 25 07:11 PM
Black Jeffrey G.Chief Financial OfficerFeb 24 '26Sale3.611,5845,718267,442Feb 25 07:11 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M
QQQSInvesco NASDAQ Future Gen 200 ETFAUM: 20.53M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-10-0.250-0.182-0.25018.4218.347
2026Q22026-08-04-0.130-0.191-0.13219.9417.807
2026Q12026-05-11-0.170-0.233-0.16617.3116.417
2025Q42026-03-10-0.200-0.190-0.19816.6316.577
2025Q32025-11-04-0.310-0.157-0.30917.2416.888
2025Q22025-07-29-0.210-0.150-0.21117.2016.317
2025Q12025-05-05-0.200-0.202-0.20215.5014.556
2024Q42025-03-11-0.200-0.256-0.20413.6613.596
2024Q32024-11-12-0.280-0.290-0.27512.5113.576
2024Q22024-08-05-0.160-0.340-0.16315.0613.136
2024Q12024-05-13-0.190-0.361-0.18714.4213.096
2023Q42024-03-18-0.310-0.431-0.31313.7711.566
2023Q32023-11-13-0.310-0.470-0.30613.4210.336
2023Q22023-08-07-0.280-0.496-0.28414.1410.936
2023Q12023-05-15-0.440-0.562-0.43911.239.416
2022Q42023-03-20-0.830-0.767-0.83512.848.666

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-8.460-5.475-2.41140.3940.55
2020FY-1.320-1.444-1.31941.9839.98
2021FY-1.680-1.754-1.68148.3047.30
2022FY-2.770-2.706-2.77445.5641.59
2023FY-1.340-1.469-1.34052.5550.32
2024FY-0.830-0.889-0.83055.6455.49
2025FY-0.930-0.880-0.93066.5866.48
2026FY--0.696--73.74
2027FY--0.539--80.23
2028FY--0.392--88.52
2029FY--0.055--104.2
2030FY-0.090--119.5

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1071218.1517.1018.80
2026Q4S2026-10-1870018.3318.1018.80
2026Q4S2026-08-0473118.3318.1018.80
2026Q4S2026-07-2570018.0817.4018.60
2026Q4S2026-07-1070518.0817.4018.60
2026Q4S2026-07-0170518.0917.4018.60
2026Q4S2026-06-2380518.0817.4018.60
2026Q4S2026-05-2470518.0717.4018.60
2026Q4S2026-05-1170718.0717.4018.60
2026Q4S2026-04-1071518.4117.8018.95
2026Q4S2026-04-0870618.2917.8018.95
2026Q4S2026-03-1070718.2917.8018.95
2026Q4S2026-03-0270419.3118.1021.20
2026Q4S2026-02-2380419.4218.1021.20

Estimate history

EPS, annual-2.723-1.536-2.411-1.319-1.681-2.774-1.34-0.83-0.925-0.7517
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.275-0.204-0.202-0.211-0.309-0.198-0.166-0.132-0.255
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual26.80732.4440.38741.97548.29945.56352.54855.64166.57572.3
Period201720182019202020212022202320242025TTM
Sales, quarterly12.50713.65515.49817.20217.24416.63117.30619.94118.417
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual12.03512.03512.56112.65216.16516.5517.04617.6422.91225.42
Period201720182019202020212022202320242025MRQ
Shares, quarterly17.5217.6417.9521.99922.5122.91224.08824.19325.42
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue72.3066.5855.6452.5545.5648.3041.9840.3932.44
Cost of Goods Sold Incl. D&A29.8327.7822.5323.0924.2120.5916.5618.8115.52
Gross Profit42.4638.8033.1129.4621.3527.7125.4221.5816.92
Selling, General and Administrative Excl. Other56.4052.8746.7552.2961.8951.7840.4030.8821.80
Research and Development6.566.255.384.879.887.243.572.182.12
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-13.93-14.07-13.64-22.84-40.55-24.07-14.98-9.30-4.88
Interest Expense5.004.322.232.332.452.622.563.492.87
Unusual Expense0.141.800.000.005.510.000.20-0.270.32
Net Income Before Taxes-18.12-19.90-15.10-23.66-47.67-26.68-16.77-12.01-7.95
Income Taxes0.050.050.010.03-0.280.17-0.080.030.06
Consolidated Net Income-18.17-19.95-15.12-23.69-47.39-26.85-16.69-25.64-9.16
Net Income From Continuing Operations-18.17-19.95-15.12-23.69-47.39-26.85-16.69-25.64-9.16
Net Income-18.17-19.95-15.12-23.69-47.39-26.85-16.69-30.28-18.48
EPS (Recurring)-0.73-0.87-0.83-1.34-2.55-1.68-1.31-2.43-1.52
EPS (Basic, Before Extraordinaries)-0.75-0.93-0.83-1.34-2.77-1.68-1.32-2.41-1.54
EPS (Diluted)-0.75-0.93-0.83-1.34-2.77-1.68-1.32-2.41-1.54
EBITDA-11.46-11.95-11.91-20.67-38.44-23.12-14.44-8.71-4.15
Non-Operating Income (Expense)0.940.290.771.520.830.020.980.510.11
Other After Tax Adjustments0.000.000.000.000.000.000.00-13.60-1.15
Stock Option Compensation Expense3.031.701.392.863.723.451.970.420.08
Price To Sales Ratio2.791.971.340.670.903.853.987.90-
Gross Margin58.7458.2859.5156.0646.8657.3760.5553.4352.16
Operating Margin-19.27-21.13-24.51-43.46-88.99-49.83-35.70-23.02-15.04
Net Margin-25.14-29.97-27.17-45.08-104.00-55.59-39.75-74.97-56.97
Shares Outstanding25.4222.9117.6417.0516.5516.1612.6512.5612.03
Market Capitalization121.97121.9772.3133.9239.17187.99167.01319.05326.46

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue18.4219.9417.3116.6317.2417.2015.5013.65
Cost of Goods Sold Incl. D&A7.587.727.107.427.176.816.385.18
Gross Profit10.8412.2210.219.2110.0710.399.128.48
Selling, General and Administrative Excl. Other14.6613.9413.6214.1813.1813.0312.4911.86
Research and Development1.821.431.551.761.731.481.281.66
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-3.82-1.72-3.41-4.97-3.10-2.63-3.37-3.38
Interest Expense1.201.201.271.331.321.120.550.56
Unusual Expense1.500.43-0.18-1.602.670.730.000.00
Net Income Before Taxes-6.34-3.20-3.93-4.66-7.09-4.40-3.75-3.75
Income Taxes-0.000.000.040.010.000.040.000.01
Consolidated Net Income-6.34-3.20-3.97-4.67-7.09-4.44-3.75-3.76
Net Income From Continuing Operations-6.34-3.20-3.97-4.67-7.09-4.44-3.75-3.76
Net Income-6.34-3.20-3.97-4.67-7.09-4.44-3.75-3.76
EPS (Recurring)-0.21-0.12-0.17-0.25-0.23-0.19-0.20-0.20
EPS (Basic, Before Extraordinaries)-0.26-0.13-0.17-0.20-0.31-0.21-0.20-0.20
EPS (Diluted)-0.26-0.13-0.17-0.20-0.31-0.21-0.20-0.20
EBITDA-3.17-1.09-2.81-4.38-2.49-2.16-2.92-2.97
Non-Operating Income (Expense)0.180.150.570.040.000.090.160.20
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.980.980.520.560.470.350.420.06
Price To Sales Ratio2.791.581.052.153.962.501.171.36
Gross Margin58.8461.2758.9755.3558.4360.4358.8762.08
Operating Margin-20.75-8.64-19.73-29.91-17.98-15.29-21.71-24.77
Net Margin-34.40-16.03-22.92-28.10-41.10-25.81-24.21-27.54
Shares Outstanding25.4224.1924.0922.9122.5122.0017.9517.64
Market Capitalization121.97112.3472.16137.79241.82152.5964.2572.31

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments32.2222.0436.4962.3999.4457.4572.0813.1611.24
Short Term Receivables10.867.836.556.089.658.915.715.950.60
Inventories3.305.722.871.791.090.000.000.000.00
Other Current Assets2.520.861.932.352.554.163.452.201.42
Total Current Assets48.8936.4547.8472.61112.7370.5281.2521.3113.26
Net Property, Plant & Equipment8.377.688.4913.084.772.101.381.571.34
Total Investments and Advances0.200.200.200.200.100.100.100.100.10
Intangible Assets---0.005.515.515.515.515.65
Deferred Tax Assets1.180.71-1.410.720.64-0.430.39
Other Assets0.560.350.420.330.330.150.070.400.04
Total Assets59.2045.4056.9487.63124.1779.0188.3129.3120.78
Short Term Debt Incl. Current Port. of LT Debt3.001.721.731.930.590.310.243.830.03
Accounts Payable4.154.143.133.052.493.011.481.281.77
Other Current Liabilities7.007.657.044.656.245.454.183.843.19
Total Current Liabilities14.1613.5111.909.629.328.775.898.954.99
Long Term Debt24.6621.6421.9934.1227.4826.6625.8526.1219.70
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities1.180.71-1.411.030.800.260.670.60
Other Liabilities1.750.000.360.021.410.950.640.300.12
Total Liabilities41.7535.8634.2545.1739.2337.1732.6536.0525.42
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.00105.2392.05
Common Equity17.459.5422.6942.4684.9441.8455.66-111.97-96.68
Total Shareholders Equity17.459.5422.6942.4684.9441.8455.66-6.73-4.64
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity17.459.5422.6942.4684.9441.8455.66-6.73-4.64
Total Liabilities & Stockholders Equity59.2045.4056.9487.63124.1779.0188.3129.3120.78
Book Value Per Share0.760.541.332.575.253.314.43-9.30-8.03
Tangible Book Value Per Share0.760.541.332.574.912.873.99-9.76-8.50
Full-Time Employees216209179204222183156--
Price to Book Ratio9.295.581.230.702.213.995.735.57-
Return on Assets-38.15-29.54-32.77-44.75-26.43-19.95-43.59-36.59-
Return on Equity-147.85-93.78-72.72-74.39-42.36-34.23-104.81--
Return on Invested Capital-47.38-48.47-53.01-61.88-23.89-24.36-31.45-47.27-181.99
Quick Ratio3.222.283.787.3611.988.0413.782.382.66
Current Ratio3.452.704.027.5512.108.0413.782.382.66

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-18.17-19.95-15.12-23.69-47.39-26.85-16.69-12.04-8.01
Depreciation2.482.121.723.112.520.950.550.590.73
Other Funds (Non Cash)5.206.193.195.7911.365.553.501.561.54
Funds from Operations-10.49-11.64-10.20-14.79-33.81-20.21-12.75-9.88-5.71
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-1.52-1.98-3.080.331.67-0.06-1.340.17-3.59
Cash from Operating Activities-12.02-13.62-13.28-14.46-32.14-20.27-14.08-9.71-9.30
Capital Expenditures-1.01-0.64-0.52-0.83-4.32-2.42-0.46-0.40-0.20
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.010.010.000.020.000.000.000.300.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00-2.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.002.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-1.00-0.63-0.52-0.80-4.32-2.42-0.46-0.10-0.20
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock6.9122.420.200.310.4565.210.1768.872.72
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock6.9122.420.200.310.4565.210.1768.872.72
Proceedsfrom Stock Options6.420.000.000.000.3965.090.1668.872.72
Issuance or Reduction of Debt, Net-1.452.01-0.86-10.94-0.70-0.53-0.27-0.148.71
Change in Long Term Debt-1.452.01-0.86-10.94-0.70-0.53-0.27-0.148.71
Issuance of Long Term Debt-0.8722.800.000.000.000.002.840.008.74
Reduction of Long Term Debt-0.58-20.79-0.86-10.94-0.70-0.53-3.11-0.14-0.04
Net Financing Active Other Cash Flow0.000.000.000.00-0.240.000.000.000.00
Other Financing Activities Uses0.000.000.000.00-0.240.000.000.000.00
Cash from Financing Activities5.4624.43-0.66-10.63-0.4964.68-0.1068.7311.42
Net Change in Cash-7.5610.18-14.46-25.90-36.9541.99-14.6458.921.92
Free Cash Flow-13.03-14.27-13.79-15.29-36.46-22.64-14.54-10.11-9.50
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00--
Deferred Taxes & Investment Tax Credit-0.000.000.00-0.310.15-0.110.000.03

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments28.0924.5921.5132.2235.6530.03
Short Term Receivables11.4812.4115.7710.8611.0914.27
Inventories4.074.164.103.303.523.74
Other Current Assets1.691.702.202.522.322.94
Total Current Assets45.3342.8643.5848.8952.5950.99
Net Property, Plant & Equipment9.418.527.798.379.186.51
Total Investments and Advances0.200.200.200.200.200.20
Deferred Tax Assets---1.18--
Other Assets0.410.360.380.560.851.06
Total Assets55.3551.9451.9659.2062.8258.76
Short Term Debt Incl. Current Port. of LT Debt2.382.592.953.003.011.83
Accounts Payable3.754.444.164.153.562.51
Other Current Liabilities6.976.435.457.006.335.96
Total Current Liabilities13.1013.4612.5614.1612.8910.29
Long Term Debt26.3825.0724.1924.6625.1623.38
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---1.18--
Other Liabilities2.101.190.771.756.634.05
Total Liabilities41.5839.7237.5241.7544.6937.73
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity13.7812.2214.4317.4518.1421.03
Total Shareholders Equity13.7812.2214.4317.4518.1421.03
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity13.7812.2214.4317.4518.1421.03
Total Liabilities & Stockholders Equity55.3551.9451.9659.2062.8258.76
Book Value Per Share0.540.500.600.760.810.96
Tangible Book Value Per Share0.540.500.600.760.810.96
Full-Time Employees---216--
Price to Book Ratio9.297.763.947.5511.4919.57
Return on Assets-30.75-34.19-43.72-38.15-35.78-31.42
Return on Equity-113.88-113.82-193.58-147.85-122.81-87.94
Return on Invested Capital-15.78-8.57-10.27-11.10-16.37-10.00
Quick Ratio3.152.883.143.223.814.59
Current Ratio3.463.183.473.454.084.95

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-6.34-3.20-3.97-4.67-7.09-4.44
Depreciation0.650.630.600.600.610.47
Other Funds (Non Cash)2.731.980.72-0.243.462.21
Funds from Operations-2.95-0.59-2.64-4.31-3.02-1.77
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.384.57-7.771.305.96-1.12
Cash from Operating Activities-2.583.99-10.42-3.012.94-2.88
Capital Expenditures-0.20-0.54-0.23-0.04-0.28-0.21
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.010.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.20-0.54-0.23-0.04-0.28-0.21
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock6.660.000.29-0.043.4818.78
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock6.660.000.29-0.043.4818.78
Proceedsfrom Stock Options6.420.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.38-0.37-0.36-0.35-0.543.15
Change in Long Term Debt-0.38-0.37-0.36-0.35-0.543.15
Issuance of Long Term Debt0.000.000.00-0.870.0023.67
Reduction of Long Term Debt-0.38-0.37-0.360.52-0.54-20.52
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities6.28-0.37-0.06-0.382.9521.93
Net Change in Cash3.503.08-10.71-3.435.6218.84
Free Cash Flow-2.773.44-10.64-3.062.67-3.09

Revenue breakdown

United States2024: 55.64M 2025: 66.58M
Client Direct Bill2024: 11.36M 2025: 14.64M
Commercial2024: 29.60M 2025: 35.76M
Government2024: 14.32M 2025: 15.88M
Other Customer2024: 358.00K 2025: 286.00K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.05%0.7M14.4M366.36K
2026-10-154.68%0.7M14.4M342.18K
2026-09-304.83%0.7M14.6M317.81K
2026-09-155.49%0.8M14.6M310.54K
2026-08-315.93%0.9M14.6M329.39K
2026-08-146.35%0.9M14.8M347.25K
2026-07-316.11%0.9M14.8M396.41K
2026-07-156.63%1.0M14.8M394.10K
2026-06-305.84%0.8M13.9M386.93K
2026-06-154.55%0.6M13.9M389.73K
2026-05-296.23%0.9M13.9M395.37K
2026-05-154.72%0.7M15.2M371.96K
2026-04-304.45%0.7M16.3M301.63K
2026-04-154.66%0.7M15.7M383.07K
2026-03-319.99%1.5M15.4M463.71K
2026-03-137.44%1.1M15.4M481.04K
2026-02-277.40%1.1M14.5M454.42K
2026-02-136.12%0.9M14.5M467.65K
2026-01-304.16%0.6M14.1M478.77K
2026-01-1511.71%1.8M15.3M398.01K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.904.400.0017.1630.000.000.957-0.0120.001
call5.000.002.450.008.3750.000.000.749-0.1210.002
call7.500.002.152.159.14253.000.000.667-0.1470.003
call10.000.002.150.3010.2871.000.000.645-0.1700.003
call12.500.002.150.2811.0931.000.000.632-0.1850.003
call15.000.000.250.004.6520.000.000.161-0.0500.002
put2.500.002.150.003.0350.000.00-0.043-0.0120.001
put5.000.002.500.508.71520.0020.00-0.251-0.1200.002
put7.500.654.201.507.73745.000.00-0.333-0.1470.003
put10.003.106.600.008.5930.000.00-0.355-0.1690.003
put12.505.709.103.509.4231.000.00-0.368-0.1840.003
put15.008.2011.600.0010.0580.000.00-0.837-0.0540.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-108-KCurrent report2026-11-10SEC
2026-11-10S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-10-204Statement of changes in beneficial ownership of securities2026-10-19SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-16SEC
2026-10-193Initial statement of beneficial ownership of securities2026-10-16SEC
2026-09-024Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-08-244/A2026-06-09SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-08-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-098-KCurrent report2026-06-09SEC
2026-05-27SCHEDULE 13GSEC
2026-05-20SCHEDULE 13G/ASEC
2026-05-12S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-05-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-118-KCurrent report2026-05-11SEC
2026-04-27ARSAnnual report to security holders. 2025-12-31SEC
2026-04-27DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-27DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-09SEC
2026-04-238-KCurrent report2026-04-17SEC
2026-04-213/A2025-07-17SEC
2026-03-164Statement of changes in beneficial ownership of securities2026-03-12SEC
2026-03-164Statement of changes in beneficial ownership of securities2026-03-12SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1191.24K269.17K1
2026-10104.44K1269.79K1
2026-0900148.78K1
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030056.83K1
2026-020046.98K2
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
WEXFORD CAPITAL LP3.28%
NANO CAP NEW MILLENNIUM GROWTH FUND L P2.79%
VANGUARD CAPITAL MANAGEMENT LLC2.54%
FourWorld Capital Management LLC2.47%
SILVERCREST ASSET MANAGEMENT GROUP LLC2.13%
First Eagle Investment Management, LLC2.13%
KENNEDY CAPITAL MANAGEMENT LLC2.01%
Mink Brook Asset Management LLC1.97%
JANE STREET GROUP, LLC1.33%
ACADIAN ASSET MANAGEMENT LLC1.29%

Funds

Fund% owned
First Eagle Small Cap Opportunity Fund1.80%
VANGUARD TOTAL STOCK MARKET INDEX FUND1.72%
VANGUARD EXTENDED MARKET INDEX FUND0.74%
Fidelity Extended Market Index Fund0.27%
iShares Micro-Cap ETF0.23%
Fidelity Total Market Index Fund0.13%
Fidelity Series Total Market Index Fund0.12%
Dimensional U.S. Small Cap ETF0.10%
NORTH SQUARE KENNEDY MICROCAP FUND0.10%
Ultra-Small Company Market Fund0.10%

OakChart. XGN. Cached 15 minutes.